Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today it has signed a five-year agreement with Biolog-id to exclusively market, sell and distribute the Biolog-id RFID (radio frequency identification) blood tracking and traceability system in Europe and the United States. The system is already CE Marked in Europe, and the companies plan to submit it for clearance to the U.S. Food and Drug Administration.
Read moreRESEAUMATIQUE, specialist integrator of the automatic and RFID identification solutions, presents the BIOLOG system, the solution to traceability and management of Labile Blood Products. This innovative application allows the reliable and dynamic follow up of the information linked to the blood pocket (gift no., group ABO (D), extensive phenotypes, name, first name, date of birth of the patient...) all along the transfusional chain. The system BIOLOG is at present in a phase of qualification for the EFS Pays de la Loire and the Polyclinic of Cholet, with the support of OSEO ANVAR.
Read more
Press releases